GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (WBO:TKD) » Definitions » Short Interest

Takeda Pharmaceutical Co (WBO:TKD) Short Interest


View and export this data going back to 2021. Start your Free Trial

What is Takeda Pharmaceutical Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Takeda Pharmaceutical Co's Short Interest

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Takeda Pharmaceutical Co's Short Interest Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Short Interest distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's Short Interest falls into.


Takeda Pharmaceutical Co (WBO:TKD) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (WBO:TKD) » Definitions » Short Interest
Comparable Companies
TSE:4523 TSE:4507 TSE:4581 TSE:4516 TSE:4530 TSE:4887 TSE:4540 TSE:4506 TSE:4547 TSE:4521 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA XSWX:SDZ VTRS NBIX SZSE:000538 NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
TAK:USA TKPHF:USA TAK:Mexico 4502:Japan TKD:Germany TAKP34:Brazil
Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Website
https://www.takeda.com
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co (WBO:TKD) Headlines

No Headlines